Splash Pic

The Jeanne Loring Lab at TSRI

A Lab Dedicated To Discovering the Secret Life of Stem Cells

Home

Renowned Stem Cell Researcher Jeanne F. Loring Heads New Center at The Scripps Research Institute

LA JOLLA, CA, March 26, 2008—Professor Jeanne F. Loring, Ph.D., has been named founding director of the newly created Center for Regenerative Medicine at The Scripps Research Institute in La Jolla, California.

Loring is an internationally recognized authority in the emerging field of stem cell research, which explores the potential of these cells to differentiate into various cell types that may be used to treat diseases and conditions such as Parkinson's and Alzheimer's, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.

"The potential of stem cell research is vast," said Scripps Research President Richard A. Lerner, M.D., in announcing the creation of the new center. "It takes a scientist of Professor Loring's foresight, knowledge, and experience in basic and applied research to lead the institute's team to new discoveries that will significantly benefit human health."

"I am excited about the potential of this new center to push research in the field forward," said Loring. "I'm looking forward to growing the center in the Scripps Research traditions of cross-disciplinary collaboration and cutting-edge science."

Researchers at the Scripps Research Center for Regenerative Medicine will explore many aspects of stem cells, including embryonic, adult, and malignant cancer stem cells, from their basic biology to potential clinical applications in drug discovery, drug delivery, and cell therapy.

The new center's major mission is to provide infrastructure to support collaboration and strategic partnerships in human stem cell research and train the next generation of stem cell scientists. An intensive NIH-sponsored human embryonic stem cell laboratory course will be offered this fall, and the center will be the site of the San Diego area training course supported by the California Institute for Regenerative Medicine.